AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount ...

Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling an openness to new approaches that haven’t been validated and the National ...

Precisely, a global leader in data integrity, is introducing new Data Quality, Data Enrichment, and Location Intelligence agents for the Precisely Data Integrity Suite. Working in coordination with ...

The US Food and Drug Administration lifted Intellia's clinical hold on its gene therapy trial for patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) treated with nex-z after ...

FDA requests new study due to insufficient trial data Shares drop 36.2% New study could delay uniQure by several years, analysts warn March 2 (Reuters) - UniQure (UQ1.F), opens new tab said the U.S.

UniQure shares fell in premarket trading Monday after the Food and Drug Administration said the company's data isn't strong enough to show its Huntington's disease gene therapy is effective. Shares ...

Larger crypto payments to darknet markets were linked to higher stimulant hospitalizations and deaths in Canadian health data. Blockchain transaction data tied to cryptocurrency payments may provide ...

A BridgeBio Pharma drug developed for dwarfism increased children’s growth rates in a pivotal clinical trial, meeting the study’s main goal and boosting the daily pill’s chances to offer an ...

For many shoppers, “no artificial colors” is shorthand for a more natural product. Under the FDA’s new policy, though, that same phrase can now appear on foods with certain added colorings. Stephanie ...

Amgen has denied a request by the FDA to voluntarily withdraw its rare disease drug Tavneos from the market, the company said Tuesday as it presented quarterly financial results. Amgen explained that ...